Enzyme Inhibitor
generalA pharmacological agent that inhibits the catalytic activity of an enzyme.
10
Centers
0
Active Trials
$2.8B
Cancer Funding
Specific Cancer Types(2)
Top Centers for Enzyme Inhibitor(10)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive High-Volume Research Center | 75.6 |
| 2 | Cardinal Bernardin Cancer CenterMaywood, IL Active Research Program | 66.9 |
| 3 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 58.1 |
| 4 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 49.4 |
| 5 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive | — |
| 6 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive | — |
| 7 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive | — |
| 8 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | — |
| 9 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | — |
| 10 | UMass Memorial Health Cancer CenterWorcester, MA | — |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →